Cormorant Asset Management, LP Nevro Corp Transaction History
Cormorant Asset Management, LP
- $1.74 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding NVRO
# of Institutions
174Shares Held
37.4MCall Options Held
80.4KPut Options Held
898K-
Armistice Capital, LLC New York, NY3.62MShares$30.5 Million0.71% of portfolio
-
Black Rock Inc. New York, NY3.41MShares$28.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.17MShares$26.7 Million0.0% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO2.8MShares$23.5 Million0.5% of portfolio
-
Fred Alger Management, LLC New York, NY2.08MShares$17.5 Million0.15% of portfolio
About NEVRO CORP
- Ticker NVRO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 35,387,800
- Market Cap $298M
- Description
- Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...